These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16571430

  • 1. Preoperative esophageal cancer staging: magnetic resonance imaging of lymph node with ferumoxtran-10, an ultrasmall superparamagnetic iron oxide.
    Nishimura H, Tanigawa N, Hiramatsu M, Tatsumi Y, Matsuki M, Narabayashi I.
    J Am Coll Surg; 2006 Apr; 202(4):604-11. PubMed ID: 16571430
    [Abstract] [Full Text] [Related]

  • 2. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
    Tatsumi Y, Tanigawa N, Nishimura H, Nomura E, Mabuchi H, Matsuki M, Narabayashi I.
    Gastric Cancer; 2006 Apr; 9(2):120-8. PubMed ID: 16767368
    [Abstract] [Full Text] [Related]

  • 3. Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging.
    Deserno WM, Harisinghani MG, Taupitz M, Jager GJ, Witjes JA, Mulders PF, Hulsbergen van de Kaa CA, Kaufmann D, Barentsz JO.
    Radiology; 2004 Nov; 233(2):449-56. PubMed ID: 15375228
    [Abstract] [Full Text] [Related]

  • 4. Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization?
    Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT, Weissleder R.
    AJR Am J Roentgenol; 2006 Jan; 186(1):144-8. PubMed ID: 16357394
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study.
    Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P, Saini S, Maravilla KR, Feldman DE, Schmiedl UP, Brunberg JA, Francis IR, Harms SE, Som PM, Tempany CM, Group.
    Radiology; 2003 Sep; 228(3):777-88. PubMed ID: 12954896
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Harada T, Tanigawa N, Matsuki M, Nohara T, Narabayashi I.
    Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria.
    Tokuhara T, Tanigawa N, Matsuki M, Nomura E, Mabuchi H, Lee SW, Tatsumi Y, Nishimura H, Yoshinaka R, Kurisu Y, Narabayashi I.
    Gastric Cancer; 2008 Sep; 11(4):194-200. PubMed ID: 19132480
    [Abstract] [Full Text] [Related]

  • 8. Rectal cancer: mesorectal lymph nodes at MR imaging with USPIO versus histopathologic findings--initial observations.
    Koh DM, Brown G, Temple L, Raja A, Toomey P, Bett N, Norman AR, Husband JE.
    Radiology; 2004 Apr; 231(1):91-9. PubMed ID: 14976266
    [Abstract] [Full Text] [Related]

  • 9. High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results.
    Kimura K, Tanigawa N, Matsuki M, Nohara T, Iwamoto M, Sumiyoshi K, Tanaka S, Takahashi Y, Narumi Y.
    Breast Cancer; 2010 Oct; 17(4):241-6. PubMed ID: 19575282
    [Abstract] [Full Text] [Related]

  • 10. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
    Memarsadeghi M, Riedl CC, Kaneider A, Galid A, Rudas M, Matzek W, Helbich TH.
    Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prostate cancer: detection of lymph node metastases outside the routine surgical area with ferumoxtran-10-enhanced MR imaging.
    Heesakkers RA, Jager GJ, Hövels AM, de Hoop B, van den Bosch HC, Raat F, Witjes JA, Mulders PF, van der Kaa CH, Barentsz JO.
    Radiology; 2009 May; 251(2):408-14. PubMed ID: 19401573
    [Abstract] [Full Text] [Related]

  • 15. Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study.
    Pultrum BB, van der Jagt EJ, van Westreenen HL, van Dullemen HM, Kappert P, Groen H, Sietsma J, Oudkerk M, Plukker JT, van Dam GM.
    Cancer Imaging; 2009 Apr 06; 9(1):19-28. PubMed ID: 19414293
    [Abstract] [Full Text] [Related]

  • 16. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
    Pannu HK, Wang KP, Borman TL, Bluemke DA.
    J Magn Reson Imaging; 2000 Dec 06; 12(6):899-904. PubMed ID: 11105028
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of nodal enhancement pattern of rectal cancer at MRI enhanced with ultrasmall superparamagnetic iron oxide: findings in pathologically matched mesorectal lymph nodes.
    Koh DM, George C, Temple L, Collins DJ, Toomey P, Raja A, Bett N, Farhat S, Husband JE, Brown G.
    AJR Am J Roentgenol; 2010 Jun 06; 194(6):W505-13. PubMed ID: 20489069
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.